Obesity

Scientists have drawn up an alternative approach to tackle obesity that retrains the minds of people highly responsive to food cues to resist cravings, and demonstrated that it may outperform current go-to strategies for long-term weight loss.

A team at Australia's Edith Cowan University have shown that when combined with the right diet, resistance training such as body-weight exercises or lifting dumbbells, can have similar effects to aerobic exercise when it comes to burning fat.

The FDA has approved a new kind of drug for type 2 diabetes. The once-weekly injection was found to be more effective at controlling blood sugar levels than current treatments, and a recent trial found it also may be useful as an anti-obesity therapy.

Obesity increases a man’s risk of dying from prostate cancer, according to a massive new study by researchers in the UK, however, the causal mechanisms underpinning the link are not yet clear.

One in five people diagnosed with type 2 diabetes are of a normal weight. A new test could help identify such people by looking for patterns of molecules in blood samples that correspond with obesity-related metabolic changes, regardless of weight.

Preliminary data from a large Phase 3 clinical trial is offering promising signs for a new anti-obesity drug. Called tirzepatide, the drug helped overweight and obese participants lose up to 22.5 percent of their total body weight over 72 weeks.

By studying the behavior of a protein tightly linked with a wide range of cancers, scientists have uncovered the role it plays in regulating body weight, deepening our understanding of the way our bodies respond to food.

While some folks might say that obese people should just exercise more and eat less, things aren't always quite that simple. A new implant is thus being designed to help boost the weight-loss process, by killing hunger-inducing cells in the stomach.

Researchers at the Mayo Clinic have shed new light on the relationship between sleep and body fat, demonstrating how a lack of sleep can increase levels of insidious visceral fat deep in the abdomen, which carries acute risks to our health.

Harvard scientists studying the molecular structure of cells under obesity-related stress have spotted alterations in the architecture that can be patched up, with "striking" results that restore them to healthy metabolic function.

Scientists have found that modifying so-called "checkpoint proteins" in the immune system can regulate inflammation in fat tissue, with the result being significant reductions in obesity and diabetes in pre-clinical models.

Through experiments involving a drug originally developed to suppress the growth of tumors, scientists have happened upon a potential new anti-obesity treatment, which they've demonstrated can trigger weight loss in mice.